Syntis Bio, a Boston-based company, is now reportedly developing an innovative daily pill aimed at mimicking the effects of gastric bypass surgery as a weight loss solution. This experimental drug creates a temporary coating in the small intestine, potentially offering an alternative to traditional
Read More